Stockreport

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares  (QNTM) 
PDF LOS ANGELES, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quantum Biopharma Ltd. (“Quantum” or the "Company") (NASDAQ: QNTM) investors of a class act [Read more]